Musculoskeletal Manifestations of Non-RA Connective Tissue Diseases: Scleroderma, Systemic Lupus Erythematosus, Still's Disease, Dermatomyositis/Polymyositis, Sjögren's Syndrome, and Mixed Connective Tissue Disease

Thibaut Jacques; Iwona Sudoł-Szopińska; Neal Larkman; Phil O'Connor; Anne Cotten

doi:10.1055/s-0038-1639473

Seminars in Musculoskeletal Radiology, Inhaltsverzeichnis

Semin Musculoskelet Radiol 2018; 22(02): 166-179
DOI: 10.1055/s-0038-1639473

Review Article

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Musculoskeletal Manifestations of Non-RA Connective Tissue Diseases: Scleroderma, Systemic Lupus Erythematosus, Still's Disease, Dermatomyositis/Polymyositis, Sjögren's Syndrome, and Mixed Connective Tissue Disease

Thibaut Jacques

¹Department of Musculoskeletal Radiology, University Hospital of Lille, Lille Cedex, France

²Lille Medical School, University of Lille, Lille, France

,

Iwona Sudoł-Szopińska

³Department of Radiology, National Institute of Geriatrics, Rheumatology and Rehabilitation; Warsaw, Poland

,

Neal Larkman

⁴Harrogate District Hospital, Harrogate, United Kingdom

,

Phil O'Connor

⁵Leeds NIHR Biomedical Research Centre, Leeds Teaching Hospitals, University of Leeds, Leeds, United Kingdom

,

Anne Cotten

¹Department of Musculoskeletal Radiology, University Hospital of Lille, Lille Cedex, France

²Lille Medical School, University of Lille, Lille, France

› Institutsangaben

Abstract

The most common systemic rheumatologic conditions are connective tissue diseases (including rheumatoid arthritis [RA]) followed by spondyloarthropathy. With the advent of biotherapies and imaging biomarkers, development in the imaging of RA and spondyloarthropathies has received substantial attention in the literature. This article details the various musculoskeletal imaging features of the other connective tissue diseases such as scleroderma and progressive systemic sclerosis, systemic lupus erythematosus, Still's disease, dermatomyositis and polymyositis, Sjögren's syndrome, and mixed connective tissue disease.

Keywords

scleroderma - lupus - dermatomyositis - polymyositis - Sjögren's syndrome

Volltext

Referenzen

References
1 Elhai M, Avouac J, Kahan A, Allanore Y. Systemic sclerosis: recent insights. Joint Bone Spine 2015; 82 (03) 148-153
2 Boonstra M, Huizinga TWJ, de Vries-Bouwstra JK. Auto-antibodies and cancer in systemic sclerosis. Autoimmun Rev 2017; 16 (08) 883-884
3 Ferreli C, Gasparini G, Parodi A, Cozzani E, Rongioletti F, Atzori L. Cutaneous manifestations of scleroderma and scleroderma-like disorders: a comprehensive review. Clin Rev Allergy Immunol 2017; 53 (03) 306-336
4 van den Hoogen F, Khanna D, Fransen J. , et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism Collaborative initiative. Ann Rheum Dis 2013; 72 (11) 1747-1755
5 Avouac J, Walker UA, Hachulla E. , et al; EUSTAR collaborators*; EUSTAR collaborators. Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective study. Ann Rheum Dis 2016; 75 (01) 103-109
6 Jaeger VK, Distler O, Maurer B. , et al. Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group. Rheumatology (Oxford) 2017; May 11 (Epub ahead of print)
7 Chitale S, Ciapetti A, Hodgson R. , et al. Magnetic resonance imaging and musculoskeletal ultrasonography detect and characterize covert inflammatory arthropathy in systemic sclerosis patients with arthralgia. Rheumatology (Oxford) 2010; 49 (12) 2357-2361
8 Bassett LW, Blocka KL, Furst DE, Clements PJ, Gold RH. Skeletal findings in progressive systemic sclerosis (scleroderma). AJR Am J Roentgenol 1981; 136 (06) 1121-1126
9 Boutry N, Hachulla E, Zanetti-Musielak C, Morel M, Demondion X, Cotten A. Imaging features of musculoskeletal involvement in systemic sclerosis. Eur Radiol 2007; 17 (05) 1172-1180
10 Schanz S, Fierlbeck G, Ulmer A. , et al. Localized scleroderma: MR findings and clinical features. Radiology 2011; 260 (03) 817-824
11 Ngo S, Vandhuick T, Janvresse A, Levesque H, Marie I. Pseudotumoral calcinosis [in French]. Rev Med Interne 2011; 32 (04) 251-252
12 Madani G, Katz RD, Haddock JA, Denton CP, Bell JR. The role of radiology in the management of systemic sclerosis. Clin Radiol 2008; 63 (09) 959-967
13 Botou A, Bangeas A, Alexiou I, Sakkas LI. Acro-osteolysis. Clin Rheumatol 2017; 36 (01) 9-14
14 Elhai M, Guerini H, Bazeli R. , et al. Ultrasonographic hand features in systemic sclerosis and correlates with clinical, biologic, and radiographic findings. Arthritis Care Res (Hoboken) 2012; 64 (08) 1244-1249
15 Low AHL, Lax M, Johnson SR, Lee P. Magnetic resonance imaging of the hand in systemic sclerosis. J Rheumatol 2009; 36 (05) 961-964
16 Allanore Y, Seror R, Chevrot A, Kahan A, Drapé JL. Hand vascular involvement assessed by magnetic resonance angiography in systemic sclerosis. Arthritis Rheum 2007; 56 (08) 2747-2754
17 Resnick D, Greenway G, Vint VC, Robinson CA, Piper S. Selective involvement of the first carpometacarpal joint in scleroderma. AJR Am J Roentgenol 1978; 131 (02) 283-286
18 Berth-Jones J, Coates PA, Graham-Brown RA, Burns DA. Neurological complications of systemic sclerosis—a report of three cases and review of the literature. Clin Exp Dermatol 1990; 15 (02) 91-94
19 La Paglia GMC, Leone MC, Lepri G. , et al. One year in review 2017: systemic lupus erythematosus. Clin Exp Rheumatol 2017; 35 (04) 551-561
20 Haute Autorité de Santé. Protocole National de Diagnostic et de Soins (PNDS): Lupus systémique. Available at: https://www.has-sante.fr/portail/jcms/c_2751894/fr/lupus-systemique . Updated 2017
21 Ben-Menachem E. Review article: systemic lupus erythematosus: a review for anesthesiologists. Anesth Analg 2010; 111 (03) 665-676
22 Pons-Estel GJ, Ugarte-Gil MF, Alarcón GS. Epidemiology of systemic lupus erythematosus. Expert Rev Clin Immunol 2017; 13 (08) 799-814
23 Lahita RG. The connective tissue diseases and the overall influence of gender. Int J Fertil Menopausal Stud 1996; 41 (02) 156-165
24 Simard JF, Costenbader KH. What can epidemiology tell us about systemic lupus erythematosus?. Int J Clin Pract 2007; 61 (07) 1170-1180
25 Barbhaiya M, Costenbader KH. Ultraviolet radiation and systemic lupus erythematosus. Lupus 2014; 23 (06) 588-595
26 Lowe GC, Henderson CL, Grau RH, Hansen CB, Sontheimer RD. A systematic review of drug-induced subacute cutaneous lupus erythematosus. Br J Dermatol 2011; 164 (03) 465-472
27 Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40 (09) 1725-1725
28 Zoma A. Musculoskeletal involvement in systemic lupus erythematosus. Lupus 2004; 13 (11) 851-853
29 Piga M, Congia M, Gabba A. , et al. Musculoskeletal manifestations as determinants of quality of life impairment in patients with systemic lupus erythematosus. Lupus 2018; 27 (02) 190-198
30 Tani C, D'Aniello D, Possemato N. , et al. MRI pattern of arthritis in systemic lupus erythematosus: a comparative study with rheumatoid arthritis and healthy subjects. Skeletal Radiol 2015; 44 (02) 261-266
31 Tani C, D'Aniello D, Delle Sedie A. , et al. Rhupus syndrome: assessment of its prevalence and its clinical and instrumental characteristics in a prospective cohort of 103 SLE patients. Autoimmun Rev 2013; 12 (04) 537-541
32 Piga M, Saba L, Gabba A. , et al. Ultrasonographic assessment of bone erosions in the different subtypes of systemic lupus erythematosus arthritis: comparison with computed tomography. Arthritis Res Ther 2016; 18 (01) 222
33 Lalani TA, Kanne JP, Hatfield GA, Chen P. Imaging findings in systemic lupus erythematosus. Radiographics 2004; 24 (04) 1069-1086
34 Nevskaya T, Gamble MP, Pope JE. A meta-analysis of avascular necrosis in systemic lupus erythematosus: prevalence and risk factors. Clin Exp Rheumatol 2017; 35 (04) 700-710
35 Oh SN, Jee WH, Cho SM. , et al. Osteonecrosis in patients with systemic lupus erythematosus: MR imaging and scintigraphic evaluation. Clin Imaging 2004; 28 (04) 305-309
36 Castro TCM, Lederman H, Terreri MTA, Caldana WI, Kaste SC, Hilário MO. The use of joint-specific and whole-body MRI in osteonecrosis: a study in patients with juvenile systemic lupus erythematosus. Br J Radiol 2011; 84 (1003): 621-628
37 Tung Chen Y, Isenberg D. Necrotising fasciitis in systemic lupus erythematosus: a case report and literature review. Lupus Sci Med 2014; 1 (01) e000008
38 Meesiri S. Pyomyositis in a patient with systemic lupus erythaematosus and a review of the literature. BMJ Case Rep 2016; ; April 28.
39 Chander S, Gordon P. Soft tissue and subcutaneous calcification in connective tissue diseases. Curr Opin Rheumatol 2012; 24 (02) 158-164
40 Egol KA, Jazrawi LM, DeWal H, Su E, Leslie MP, Di Cesare PE. Orthopaedic manifestations of systemic lupus erythematosus. Bull Hosp Jt Dis 2001; 60 (01) 29-34
41 Sierra-Jimenez G, Sanchez-Ortiz A, Aceves-Avila FJ, Hernandez-Rios G, Durán-Barragán S, Ramos-Remus C. Tendinous and ligamentous derangements in systemic lupus erythematosus. J Rheumatol 2008; 35 (11) 2187-2191
42 Nakamura K, Tajima Y, Takai O. Generalized laxity of connective tissue as a possible syndrome in systemic lupus erythematosus. Mod Rheumatol 2010; 20 (05) 522-527
43 Ohta A, Yamaguchi M, Tsunematsu T. , et al. Adult Still's disease: a multicenter survey of Japanese patients. J Rheumatol 1990; 17 (08) 1058-1063
44 Pay S, Türkçapar N, Kalyoncu M. , et al; Ankara Rheumatology Study Group. A multicenter study of patients with adult-onset Still's disease compared with systemic juvenile idiopathic arthritis. Clin Rheumatol 2006; 25 (05) 639-644
45 Bywaters EG. Still's disease in the adult. Ann Rheum Dis 1971; 30 (02) 121-133
46 Pouchot J. Maladie de Still de l'adulte. Rev Med Suisse 2008; 4: 1039-1044
47 Efthimiou P, Paik PK, Bielory L. Diagnosis and management of adult onset Still's disease. Ann Rheum Dis 2006; 65 (05) 564-572
48 Ichida H, Kawaguchi Y, Sugiura T. , et al. Clinical manifestations of adult-onset Still's disease presenting with erosive arthritis: association with low levels of ferritin and interleukin-18. Arthritis Care Res (Hoboken) 2014; 66 (04) 642-646
49 Lilleker JB, Vencovsky J, Wang G. , et al; all EuroMyositis contributors. The EuroMyositis registry: an international collaborative tool to facilitate myositis research. Ann Rheum Dis 2018; 77 (01) 30-39
50 Corral-Magaña O, Bauzá-Alonso AF, Escudero-Góngora MM, Lacruz L, Martín-Santiago A. Juvenile dermatomyositis: key roles of muscle magnetic resonance imaging and early aggressive treatment. Actas Dermosifiliogr 2017; September 11 (Epub ahead of print)
51 Ramos-Casals M, Brito-Zerón P, Sisó-Almirall A, Bosch X. Primary Sjogren syndrome. BMJ 2012; 344: e3821
52 Hajiabbasi A, Shenavar Masooleh I, Alizadeh Y, Banikarimi AS, Ghavidel Parsa P. Secondary Sjogren's syndrome in 83 patients with rheumatoid arthritis. Acta Med Iran 2016; 54 (07) 448-453
53 Hatron P-Y. Syndrome de Gougerot-Sjögren. EMC Traité Médecine AKOS 2010; 5 (02) 1-6
54 Vitali C, Bombardieri S, Jonsson R. , et al; European Study Group on Classification Criteria for Sjögren's Syndrome. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61 (06) 554-558
55 Iagnocco A, Modesti M, Priori R. , et al. Subclinical synovitis in primary Sjögren's syndrome: an ultrasonographic study. Rheumatology (Oxford) 2010; 49 (06) 1153-1157
56 Shuckett R, Russell ML, Gladman DD. Atypical erosive osteoarthritis and Sjögren's syndrome. Ann Rheum Dis 1986; 45 (04) 281-288
57 Ballard M, Meyer O, Adle-Biassette H, Grossin M. Jaccoud's arthropathy with vasculitis and primary Sjögren's syndrome. A new entity. Clin Exp Rheumatol 2006; 24 (02) (Suppl. 41) S102-S103
58 Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease—an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972; 52 (02) 148-159
59 Ungprasert P, Crowson CS, Chowdhary VR, Ernste FC, Moder KG, Matteson EL. Epidemiology of mixed connective tissue disease, 1985–2014: a population-based study. Arthritis Care Res (Hoboken) 2016; 68 (12) 1843-1848
60 Ciang NCO, Pereira N, Isenberg DA. Mixed connective tissue disease—enigma variations?. Rheumatology (Oxford) 2017; 56 (03) 326-333